Overview
Nexlizet is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with heterozygous familial hypercholesterolemia or established atherosclerotic cardiovascular disease who… read more
Overview
Nexletol is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with heterozygous familial hypercholesterolemia or established atherosclerotic cardiovascular disease who… read more
Overview
Camzyos is approved by the U.S. Food and Drug Administration (FDA) to treat adults with symptomatic New York Heart Association class 2 and 3 obstructive hypertrophic cardiomyopathy (HCM). Camzyos is also known by…
Overview
Inspra is approved by the U.S. Food and Drug Administration (FDA) to improve survival in people with symptomatic heart failure after a heart attack and to treat hypertension (high blood pressure). For heart…
Overview
Jardiance is approved by the U.S. Food and Drug Administration (FDA) to reduce the risk of cardiovascular death and hospitalization for heart failure in adults with heart failure. It is suitable for adults with…
Overview
Farxiga is approved by the U.S. Food and Drug Administration (FDA) to reduce the risk of cardiovascular death, hospitalization for heart failure, and urgent heart failure visits in adults with heart failure…
Overview
Savaysa, approved by the U.S. Food and Drug Administration (FDA), is indicated to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation (irregular heart rhythm unrelated…
Overview
Multaq is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with paroxysmal (sudden and short-lasting episodes) or persistent (continuous) atrial fibrillation (AF) or… read more
Overview
Ranexa is a prescription drug approved by the Food and Drug Administration (FDA) to treat chronic angina (chest pain and pressure). Ranexa is also known by its drug name, Ranolazine.
Ranexa is a member of a… read more
Overview
Widaplik is approved by the U.S. Food and Drug Administration (FDA) for the treatment of hypertension (high blood pressure), including use as an initial treatment. People who need combination therapy to…